MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

HPV Genotype Attribution and Disease Burden of Anal Cancer in China

Not yet recruiting
Conditions
Anal Cancer
First Posted Date
2024-11-01
Last Posted Date
2024-11-01
Lead Sponsor
Fudan University
Target Recruit Count
300
Registration Number
NCT06670495

To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery

Phase 4
Not yet recruiting
Conditions
Colorectal Cancer
Interventions
First Posted Date
2024-10-30
Last Posted Date
2024-10-31
Lead Sponsor
Fudan University
Target Recruit Count
134
Registration Number
NCT06665334

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Phase 2
Not yet recruiting
Conditions
Colon Cancer
Rectal Cancer
Interventions
Drug: Ultrafractionated RT and CGA Guided systemic treatment.
Radiation: Ultrafractionated Radiotherapy
Drug: PD-1 antibody
Drug: Chemotherapy (CPT-11)
Drug: Chemotherapy (Fluorouracil)
Drug: Targeted Therapy (anti-VEGF)
Drug: Chemotherapy (Raltitrexed)
Drug: Targeted Therapy (anti-EGFR)
Drug: Chemotherapy (Oxaliplatin)
First Posted Date
2024-10-30
Last Posted Date
2024-10-30
Lead Sponsor
Fudan University
Target Recruit Count
110
Registration Number
NCT06665087

Vaccine Chatbot for Improving Influenza Vaccination Uptake

Not Applicable
Not yet recruiting
Conditions
Influenza Vaccines
First Posted Date
2024-10-24
Last Posted Date
2024-10-24
Lead Sponsor
Fudan University
Target Recruit Count
1200
Registration Number
NCT06657573
Locations
🇨🇳

Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China

Acute Effects of Cold Exposure on Cognitive Function

Not Applicable
Active, not recruiting
Conditions
Cognitive Function
First Posted Date
2024-10-23
Last Posted Date
2025-02-27
Lead Sponsor
Fudan University
Target Recruit Count
40
Registration Number
NCT06654167
Locations
🇨🇳

Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China

Combination of TURP and Standard Systemic Therapy for MPCa

Phase 2
Recruiting
Conditions
Metastatic Prostate Cancer
Interventions
Procedure: TURP
Drug: Standard Medical Therapy
First Posted Date
2024-10-23
Last Posted Date
2024-10-23
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT06655259
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Completed
Conditions
Breast Cancer
First Posted Date
2024-10-23
Last Posted Date
2025-05-07
Lead Sponsor
Fudan University
Target Recruit Count
473
Registration Number
NCT06655545
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Cola Ingestion for Esophageal Bolus Impaction

Not Applicable
Recruiting
Conditions
Esophageal Cancer
First Posted Date
2024-10-22
Last Posted Date
2024-10-22
Lead Sponsor
Fudan University
Target Recruit Count
50
Registration Number
NCT06652620
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

Acute Effects of Cold Exposure on Cardiovascular System

Not Applicable
Recruiting
Conditions
Cardiovascular System
First Posted Date
2024-10-22
Last Posted Date
2025-02-27
Lead Sponsor
Fudan University
Target Recruit Count
40
Registration Number
NCT06652425
Locations
🇨🇳

Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Phase 2
Not yet recruiting
Conditions
Colon Cancer
Rectal Cancer
Interventions
Drug: Ultrafractionated RT and CGA Guided systemic treatment.
Other: data prospectively collected
Radiation: Ultrafractionated Radiotherapy
First Posted Date
2024-10-22
Last Posted Date
2024-10-28
Lead Sponsor
Fudan University
Target Recruit Count
124
Registration Number
NCT06652412
© Copyright 2025. All Rights Reserved by MedPath